Characterization of published errors in high-impact oncology journals

Por Molckovsky, A., Vickers, M.M., Tang, P.A.
Publicado em 2011

Factors associated with publication of randomized phase iii cancer trials in journals with a high impact factor

Por Tang, P.A., Pond, G.R., Welch, S., Chen, E.X.
Publicado em 2014

Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysis

Por Samawi, H.H., Shaheen, A.A., Tang, P.A., Heng, D.Y.C., Cheung, W.Y., Vickers, M.M.
Publicado no Curr Oncol (2017)

Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada

Por Tang, P.A., Hay, A.E., O’Callaghan, C.J., Mittmann, N., Chambers, C.R., Pater, J.L., Leighl, N.B.
Publicado no Curr Oncol (2016)